Article Per Year (5 Year)
p-Index From 2020 - 2025
0.408
P-Index
This Author published in this journals
All Journal Borneo Journal of Pharmacy Kartika : Jurnal Ilmiah Farmasi
Suherman, Linda Purnamawati
Unknown Affiliation
Health Professions Immunology & microbiology Materials Science & Nanotechnology Medicine & Pharmacology Social Sciences

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
PENGGUNAAN OBAT KARDIOVASKULAR PADA PASIEN PENYAKIT JANTUNG KORONER DI RUANG RAWAT INAP SALAH SATU RUMAH SAKIT DI KOTA CIMAHI Septiani, Vina; Kartidjo, Pudjiastuti; Suherman, Linda Purnamawati
Kartika : Jurnal Ilmiah Farmasi Vol 9 No 1 (2024)
Publisher : Fakultas Farmasi Universitas Jenderal Achmad Yani, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.26874/kjif.v9i1.186

Abstract

Telah dilakukan penelitian pola penggunaan obat kardiovaskular pada pasien penyakit jantung koroner (PJK) di ruang rawat inap salah satu rumah sakit di Kota Cimahi dengan menggunakan desain penelitian analisis deskriptif, yang dilakukan secara retrospektif. Tujuan penelitian ini untuk mengetahui obat-obatan yang digunakan pada pasien jantung koroner di rumah sakit tersebut. Sumber data penelitian adalah rekam medik pasien ruang rawat inap periode Oktober – Desember 2017. Hasil menunjukkan pasien kasus PJK sebanyak 42,04% berusia >60 tahun. Obat-obat dengan frekuensi penggunaan yang tinggi pasien PJK yaitu antithrombosis (ticagrelor 75,16%, fondaparinux 64,97%, dan asam asetil salisilat 29,30%), obat manajemen lipid (atorvastatin 70,06%), beta blocker (bisoprolol 70,70%), ditambah obat golongan diuretik (furosemid 72,61%) yang diberikan untuk penyakit penyerta. Studi ini menunjukkan bahwa penggunaan obat-obatan pada pasien sesuai dengan tatalaksana terapi PJK dari PERKI (Perhimpunan Dokter Spesialis Kardiovaskular Indonesia) Tahun 2018. Kata kunci:  Obat kardiovaskular, pjk, retrospektif.   Abstract The research about uses pattern of cardiovascular drugs for coronary artery disease patients at in-patient department one hospital in Cimahi City was done retrospectively use descriptive analysis design. The aim of this study was to determine the drugs used in coronary artery disease. Data source was medical record of patient who treated at in-patient department period October – December 2017. Result show that 42,04% CAD patients were over 60 years old. The most common drugs that administered to CAD patients were antithrombosis (ticagrelor 75,16%, fondaparinux 64,97%, and acetyl salicylic acid 29,30%), lipid management (atorvastatin 70,06%), beta blocker (bisoprolol 70,70%), and also diuretics (furosemid 72,61%) for co-morbidities. This study shows that the patient's medication use is in accordance with the CHD therapy management from PERKI (Indonesian Heart Association) in 2018. Keywords: Cardiovascular drugs, chd, retrospective.
Rationality of Tuberculosis Treatment for Drug-Susceptible Pulmonary Tuberculosis at a Primary Care in Bandung Islamiyah, Alfi Nurul; Syarifuddin, Syarifuddin; Akhsa, Morsalina; Rukmawati, Iis; Margayani, Eni; Suherman, Linda Purnamawati; Septiani, Vina; Ramdani, Robby
Borneo Journal of Pharmacy Vol. 7 No. 4 (2024): Borneo Journal of Pharmacy
Publisher : Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33084/bjop.v7i4.5896

Abstract

Tuberculosis (TB) remains a significant global health concern, particularly in Indonesia. Ensuring rational TB treatment is crucial for effective disease control and preventing the emergence of drug resistance. This study aimed to evaluate the rationality of TB treatment among newly diagnosed drug-susceptible pulmonary TB patients in a primary care center in Bandung. A descriptive-analytical study was conducted on 56 patients who met the inclusion and exclusion criteria. Treatment rationality was assessed based on the Indonesian Society of Respirology 2021 and the National Guidelines for Medical Services 2020. While 100% of patients received the correct medication for the right indication and dose, the duration of therapy was suboptimal for most patients (83.93%) due to drug unavailability. This resulted in a lower-than-ideal treatment regimen, potentially compromising treatment outcomes and increasing the risk of drug resistance. These findings highlight the need for improved drug supply management and adherence to treatment guidelines to optimize TB treatment outcomes and reduce the burden of TB in Indonesia.
Co-Authors Akhsa, Morsalina Islamiyah, Alfi Nurul Margayani, Eni Pudjiastuti Kartidjo, Pudjiastuti Ramdani, Robby Rukmawati, Iis Syarifuddin Syarifuddin Vina Septiani, Vina